Brought to you by:
-
Eastern Vascular gathering challenged to forge next generation of evolution
Evolution was the core theme of the Presidential Address Robert Rhee, MD, delivered from the Eastern Vascular Society (EVS) annual meeting stage in Philadelphia (Sept. 29–Oct. 1). “Let’s Evolve,” it was entitled. But, Rhee told those gathered, the society lays claim geographically to the Eastern seaboard of the United States and Canada, which is home…
-
VAM 2023: Apply for international scholars program by Dec. 31
Young vascular surgeons from outside the United States and Canada have until Dec. 31 to apply for scholarships to attend the 2023 Vascular Annual Meeting (VAM). VAM will be held June 14–17, 2023, in National Harbor, Maryland, just outside Washington, D.C. Working with a mentor, recipients—who cannot be older than 40 in the year they…
-
Spotlight: SVS members in the news
Several SVS members have been making moves recently, attracting recognition in the form of awards and promotions. Katherine Gallagher, MD, of the University of Michigan, has been elected to the National Academy of Medicine for her “innovative translational research on epigenetic regulation of immune cells during normal and pathologic tissue repair and other cardiovascular disease…
-
SWING trial 12-month data: Novel sirolimus DCB shows ‘great promise’ in ‘challenging’ CLTI population
The Sundance (Surmodics) sirolimus drug-coated balloon (DCB) has an “excellent” safety profile in a “challenging, real-world, predominantly CLTI [chronic limb-threatening ischemia] population,” and has a primary patency rate of 80% at 12 months in a per-protocol analysis population. Ramon Varcoe, MD, from Prince of Wales Hospital in Sydney, Australia, presented these findings from the SWING…
-
VEITHsymposium panel probes ‘value’ of artificial intelligence in vascular surgery
A session at the 2022 VEITHsymposium in New York City (Nov. 15–19) focused on new concepts, machine learning, and artificial intelligence (AI) in vascular surgery, with a panel discussion honing in on the cost-effectiveness and wider “value” of emerging technologies in this space. “What’s the benchmark for success going to be?” moderator Barry Katzen, MD,…
-
NESVS Robert R. Linton Lecture features complex aortic masterclass from Europe
World-leading aortic surgeon Stéphan Haulon, MD, from the Aortic Centre at Hôpital Marie Lannelongue in Paris, France, took attendees of the 2022 New England Society for Vascular Surgery (NESVS) annual meeting on a whirlwind, 15-year journey through the evolution of aortic arch endografting from his personal vantage point—the most advanced view in the world, 2021–22…
-
SOOVC sub-section introduces two awards
The Society for Vascular Surgery’s sub-section for those who provide service in outpatient settings has created two professional development opportunities for its members, a research grant and a presentation award to present already completed research. Applications for the Sub-Section on Outpatient and Office Vascular Care (SOOVC) Presentation Award and the SOOVC Research Seed Grant are…
-
SVS adds ‘service’ criterion to Distinguished Fellows process
The Society for Vascular Surgery (SVS) has added service to the Society as an important component of its Distinguished Fellows process, an honor annually bestowed upon a handful of members. This accolade goes to Active, International or Senior vascular-surgeon members who have distinguished themselves in a sustained matter by making substantial contributions in two of…
-
Virtual visits versus in-person: Telemedicine study detects ‘substantial’ cost savings for patients
Virtual consultations appear comparable to care received in-person when it comes to clinical outcomes as well as patient and practitioner satisfaction, a systematic review and meta-analysis of all primary studies evaluating virtual patient visits in vascular surgery has demonstrated. “The data tell us telemedicine can help save patients time and money. However, in considering the…
-
Disrupt PAD III observational study results confirm safety and effectiveness of IVL in complex calcified lesions
The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical) outcomes in complex and challenging lesions across multiple peripheral vessel beds. Ehrin Armstrong, MD, from an interventional cardiologist from Adventist Heart and Vascular Institute in St Helena, California, presented this conclusion during a late-breaking clinical…